p>Obesity drugs as ASCVD-modifiers, HR monito...
Plastics and heart disease, MINT trial letter...
The Western AF meeting, aspirin, cannabis use...
Reading incidental CAC on chest CT scans, exe...
An update in trial interpretation, CI, and P-...
Beta-blocker withdrawal in HFpEF, the ARCADIA...
FDA approves PFA for AF ablation, flawed comp...
LAAO, more evidence that stable CAD is stable...
Listener feedback on antiplatelet therapy aft...
GLP-1s and BaroStim Neo revisited, a new drug...